Are you Dr. Elkins?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1673Fax+1 415-353-2898
Summary
- Dr. Jacob Elkins, MD is a neurologist in San Francisco, California. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- University of California (San Francisco)Residency, Neurology, 1999 - 2002
- University of California (San Francisco)Internship, Internal Medicine, 1998 - 1999
- Harvard Medical SchoolClass of 1998
Certifications & Licensure
- MA State Medical License 2008 - 2013
Publications & Presentations
PubMed
- Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy.Craig M McDonald, Jacob S Elkins, Sai Dharmarajan, Katherine Gooch, Teofil Ciobanu
Neurology and Therapy. 2024-11-26 - 11 citationsSafety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 StudyJacqueline A. French, Andrew J. Cole, Edward Faught, William H. Theodore, Annamaria Vezzani
Neurology. 2021-11-02 - 8 citationsPost-stroke blood-brain barrier disruption predicts poor outcome in patients enrolled in the ACTION studyRichard Leigh, Emi Hitomi, R. Matthew Hutchison, Jacob Elkins
Journal of Neuroimaging. 2021-04-22
Press Mentions
- No Benefit for Natalizumab Within 9 Hours of StrokeFebruary 19th, 2016
Grant Support
- Hypertension And High Cognitive Function In The ElderlyNational Institute Of Neurological Disorders And Stroke2004–2006